# BCOR

BCOR acts as a co-repressor of BCL6, and mutations in BCOR could impair its binding affinity to BCL6 and other partners. Overall, protein-altering mutations in BCOR seem to be rare in DLBCL and MCL.<sup>1,2</sup> One study reported a much higher prevalence of a hot spot mutation in BCOR but this result has not been reproduced.<sup>1</sup> 

## Relevance tier by entity

|Entity|Tier|Description               |
|:------:|:----:|--------------------------|
|DLBCL |1   |high-confidence DLBCL gene|
|MCL   |1   |high-confidence MCL gene  |

## Mutation incidence in large patient cohorts (GAMBL reanalysis)

|Entity|source        |frequency (%)|
|:------:|:--------------:|:-------------:|
|DLBCL |GAMBL genomes |3.82         |
|DLBCL |Schmitz cohort|7.66         |
|DLBCL |Reddy cohort  |2.50         |
|DLBCL |Chapuy cohort |2.56         |
|MCL   |GAMBL genomes |3.79         |

## Mutation pattern and selective pressure estimates

|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
|BL    |No  |No                   |1.341           |0               |
|DLBCL |No  |No                   |2.471           |0               |
|FL    |No  |No                   |1.743           |0               |


> [!NOTE]
> BCOR mutations were first described in MCL in 2020 by Nadeu et al.<sup>2</sup> and in 2021 by Kang et al, although the hot spot mutation reported in that study has not been reproduced.<sup>1</sup>


 ## BCOR Hotspots

| Chromosome |Coordinate (hg19) | ref>alt | HGVSp | 
 | :---:| :---: | :--: | :---: |
| chrX | 39921444 | T>C | N1459S |

View coding variants in ProteinPaint [hg19](https://morinlab.github.io/LLMPP/GAMBL/BCOR_protein.html)  or [hg38](https://morinlab.github.io/LLMPP/GAMBL/BCOR_protein_hg38.html)

![image](images/proteinpaint/BCOR_NM_017745.svg)

View all variants in GenomePaint [hg19](https://morinlab.github.io/LLMPP/GAMBL/BCOR.html)  or [hg38](https://morinlab.github.io/LLMPP/GAMBL/BCOR_hg38.html)

![image](images/proteinpaint/BCOR.svg)

## References

1. *Kang JH, Lee SH, Lee J, Choi M, Cho J, Kim SJ, Kim WS, Ko YH, Yoo HY. The mutation of BCOR is highly recurrent and oncogenic in mature T-cell lymphoma. BMC Cancer. 2021 Jan 19;21(1):82. doi: 10.1186/s12885-021-07806-8. PMID: 33468080; PMCID: PMC7816311.*
2. *Nadeu F, Martin-Garcia D, Clot G, Díaz-Navarro A, Duran-Ferrer M, Navarro A, Vilarrasa-Blasi R, Kulis M, Royo R, Gutiérrez-Abril J, Valdés-Mas R, López C, Chapaprieta V, Puiggros M, Castellano G, Costa D, Aymerich M, Jares P, Espinet B, Muntañola A, Ribera-Cortada I, Siebert R, Colomer D, Torrents D, Gine E, López-Guillermo A, Küppers R, Martin-Subero JI, Puente XS, Beà S, Campo E. Genomic and epigenomic insights into the origin, pathogenesis, and clinical behavior of mantle cell lymphoma subtypes. Blood. 2020 Sep 17;136(12):1419-1432. doi: 10.1182/blood.2020005289. PMID: 32584970; PMCID: PMC7498364.*
## BCOR Expression
![image](images/gene_expression/BCOR_by_pathology.svg)
<!-- ORIGIN: nadeuGenomicEpigenomicInsights2020a -->
